Want to join the conversation?
St. Louis, Missouri-based pharmacy company $ESRX said that for 4Q15, it delivered adjusted EPS of $1.56, representing growth of 12% over last year. The company adjudicated 341.5MM adjusted claims generating adjusted EBITDA of $1.9Bil, up 4%, resulting in adjusted EBITDA per claim of $5.66. $ESRX generated $2.9Bil of cash flow in 4Q15.
What are your expectations from $COKE tomorrow?? Will the bear attack the beverage?
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.